How Does Nuclear Organization Maintain Normal Mammary Phenotype

Abstract

Matrix protease-mediated degradation of the basement membrane (BM) surrounding breast epithelial units (acini) is associated with tumor progression. It is critical to understand the molecular mechanisms that underlie the maintenance of an intact BM in order to develop anti-cancer strategies. Using a nonmalignant human breast epithelial cell line (sl) that differentiate into acini in the presence of extracellular matrix, we have identified earlier a link between the nuclear organization of the protein NuMA, via its C-terminus, and cell phenotype, notably matrix protease expression. We have expressed and purified the NuMA C-terminal histone-fold peptide that may be involved in the regulation of matrix proteases. Using this sequence as bait we have pulled down a 65 kDa ligand in nonmalignant cells but not in tumor cells. The histone-fold sequence has also been expressed in Sl cells and the resulting phenotype is being analyzed. We have identified a CH-actin binding domain at the N-terminus of NuMA that may be responsible for the protein anchorage to the cytoskeleton. We have also demonstrated that NuMA shuttles between nucleus and cytoplasm. Altogether our data suggest that NuMA may regulate cell phenotype not only by binding different c-terminus ligands but also by traveling between nucleus and cytoplasm.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jul 01, 2002
Accession Number
ADA408754

Entities

People

  • Sophie A Lelièvre

Organizations

  • University of California, Berkeley

Tags

DTIC Thesaurus Topics

  • Biology
  • Breast Cancer
  • Cell Membrane
  • Cell Nucleus
  • Cell Physiological Processes
  • Cells
  • Cellular Structures
  • Chemistry
  • Cytoskeleton
  • Department Of Defense
  • Health Services
  • Intranuclear Space
  • Mammary Glands
  • Proteins
  • Soft X Rays
  • Three Dimensional
  • X Rays

Fields of Study

  • Biology

Readers

  • Molecular Genetics
  • Molecular and Cellular Biochemistry
  • Oncology (Cancer Research).